Global Antiserum Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Antiserum market size was valued at USD 1326.2 million in 2023 and is forecast to a readjusted size of USD 2067.2 million by 2030 with a CAGR of 6.5% during review period.
Antiserum, is a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens.
Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals.
Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%. Among them, CSL is the leader with about 16% market share.
Asia-Pacific is the largest market, with a share about 47%, followed by North America and Middle East and Africa, with the share about 24% and 12%. In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%. And in terms of application, the largest application is Clinical, followed by Laboratory.
The Global Info Research report includes an overview of the development of the Antiserum industry chain, the market status of Clinical (Antitoxin Serum, Antibacterial Serum), Laboratory (Antitoxin Serum, Antibacterial Serum), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antiserum.
Regionally, the report analyzes the Antiserum markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antiserum market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antiserum market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antiserum industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Antitoxin Serum, Antibacterial Serum).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antiserum market.
Regional Analysis: The report involves examining the Antiserum market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antiserum market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antiserum:
Company Analysis: Report covers individual Antiserum players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antiserum This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical, Laboratory).
Technology Analysis: Report covers specific technologies relevant to Antiserum. It assesses the current state, advancements, and potential future developments in Antiserum areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antiserum market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antiserum market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Antiserum product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antiserum, with revenue, gross margin and global market share of Antiserum from 2019 to 2024.
Chapter 3, the Antiserum competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antiserum market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiserum.
Chapter 13, to describe Antiserum research findings and conclusion.
Antiserum, is a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens.
Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals.
Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
Global 5 largest manufacturers of Antiserum are CSL, Merck, BTG, Pfizer and CNBG, which make up over 58%. Among them, CSL is the leader with about 16% market share.
Asia-Pacific is the largest market, with a share about 47%, followed by North America and Middle East and Africa, with the share about 24% and 12%. In terms of product type, Antitoxin Serum occupies the largest share of the total market, about 61%. And in terms of application, the largest application is Clinical, followed by Laboratory.
The Global Info Research report includes an overview of the development of the Antiserum industry chain, the market status of Clinical (Antitoxin Serum, Antibacterial Serum), Laboratory (Antitoxin Serum, Antibacterial Serum), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antiserum.
Regionally, the report analyzes the Antiserum markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antiserum market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antiserum market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antiserum industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Antitoxin Serum, Antibacterial Serum).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antiserum market.
Regional Analysis: The report involves examining the Antiserum market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antiserum market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antiserum:
Company Analysis: Report covers individual Antiserum players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antiserum This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical, Laboratory).
Technology Analysis: Report covers specific technologies relevant to Antiserum. It assesses the current state, advancements, and potential future developments in Antiserum areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antiserum market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antiserum market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Antitoxin Serum
- Antibacterial Serum
- Antiviral Serum
- Others
- Clinical
- Laboratory
- BD
- Bio-Rad
- Shanghai Serum Bio-Technology Co., Ltd.
- China National Pharmaceutical Group
- CSL
- Merck
- BTG
- Pfizer
- Haffkine Bio-Pharmaceutical
- Vins Bioproducts
- Bharat Serums and Vaccines
- SSI Diagnostica
- GD Animal Health
- MicroPharm
- Peptide Institute Inc.
- Rare Disease Therapeutics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Antiserum product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antiserum, with revenue, gross margin and global market share of Antiserum from 2019 to 2024.
Chapter 3, the Antiserum competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antiserum market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antiserum.
Chapter 13, to describe Antiserum research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Antiserum
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antiserum by Type
1.3.1 Overview: Global Antiserum Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Antiserum Consumption Value Market Share by Type in 2023
1.3.3 Antitoxin Serum
1.3.4 Antibacterial Serum
1.3.5 Antiviral Serum
1.3.6 Others
1.4 Global Antiserum Market by Application
1.4.1 Overview: Global Antiserum Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinical
1.4.3 Laboratory
1.5 Global Antiserum Market Size & Forecast
1.6 Global Antiserum Market Size and Forecast by Region
1.6.1 Global Antiserum Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Antiserum Market Size by Region, (2019-2030)
1.6.3 North America Antiserum Market Size and Prospect (2019-2030)
1.6.4 Europe Antiserum Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Antiserum Market Size and Prospect (2019-2030)
1.6.6 South America Antiserum Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Antiserum Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Antiserum Product and Solutions
2.1.4 BD Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BD Recent Developments and Future Plans
2.2 Bio-Rad
2.2.1 Bio-Rad Details
2.2.2 Bio-Rad Major Business
2.2.3 Bio-Rad Antiserum Product and Solutions
2.2.4 Bio-Rad Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bio-Rad Recent Developments and Future Plans
2.3 Shanghai Serum Bio-Technology Co., Ltd.
2.3.1 Shanghai Serum Bio-Technology Co., Ltd. Details
2.3.2 Shanghai Serum Bio-Technology Co., Ltd. Major Business
2.3.3 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product and Solutions
2.3.4 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Shanghai Serum Bio-Technology Co., Ltd. Recent Developments and Future Plans
2.4 China National Pharmaceutical Group
2.4.1 China National Pharmaceutical Group Details
2.4.2 China National Pharmaceutical Group Major Business
2.4.3 China National Pharmaceutical Group Antiserum Product and Solutions
2.4.4 China National Pharmaceutical Group Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 China National Pharmaceutical Group Recent Developments and Future Plans
2.5 CSL
2.5.1 CSL Details
2.5.2 CSL Major Business
2.5.3 CSL Antiserum Product and Solutions
2.5.4 CSL Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CSL Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Antiserum Product and Solutions
2.6.4 Merck Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Merck Recent Developments and Future Plans
2.7 BTG
2.7.1 BTG Details
2.7.2 BTG Major Business
2.7.3 BTG Antiserum Product and Solutions
2.7.4 BTG Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BTG Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Antiserum Product and Solutions
2.8.4 Pfizer Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Haffkine Bio-Pharmaceutical
2.9.1 Haffkine Bio-Pharmaceutical Details
2.9.2 Haffkine Bio-Pharmaceutical Major Business
2.9.3 Haffkine Bio-Pharmaceutical Antiserum Product and Solutions
2.9.4 Haffkine Bio-Pharmaceutical Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Haffkine Bio-Pharmaceutical Recent Developments and Future Plans
2.10 Vins Bioproducts
2.10.1 Vins Bioproducts Details
2.10.2 Vins Bioproducts Major Business
2.10.3 Vins Bioproducts Antiserum Product and Solutions
2.10.4 Vins Bioproducts Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Vins Bioproducts Recent Developments and Future Plans
2.11 Bharat Serums and Vaccines
2.11.1 Bharat Serums and Vaccines Details
2.11.2 Bharat Serums and Vaccines Major Business
2.11.3 Bharat Serums and Vaccines Antiserum Product and Solutions
2.11.4 Bharat Serums and Vaccines Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bharat Serums and Vaccines Recent Developments and Future Plans
2.12 SSI Diagnostica
2.12.1 SSI Diagnostica Details
2.12.2 SSI Diagnostica Major Business
2.12.3 SSI Diagnostica Antiserum Product and Solutions
2.12.4 SSI Diagnostica Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 SSI Diagnostica Recent Developments and Future Plans
2.13 GD Animal Health
2.13.1 GD Animal Health Details
2.13.2 GD Animal Health Major Business
2.13.3 GD Animal Health Antiserum Product and Solutions
2.13.4 GD Animal Health Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 GD Animal Health Recent Developments and Future Plans
2.14 MicroPharm
2.14.1 MicroPharm Details
2.14.2 MicroPharm Major Business
2.14.3 MicroPharm Antiserum Product and Solutions
2.14.4 MicroPharm Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 MicroPharm Recent Developments and Future Plans
2.15 Peptide Institute Inc.
2.15.1 Peptide Institute Inc. Details
2.15.2 Peptide Institute Inc. Major Business
2.15.3 Peptide Institute Inc. Antiserum Product and Solutions
2.15.4 Peptide Institute Inc. Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Peptide Institute Inc. Recent Developments and Future Plans
2.16 Rare Disease Therapeutics
2.16.1 Rare Disease Therapeutics Details
2.16.2 Rare Disease Therapeutics Major Business
2.16.3 Rare Disease Therapeutics Antiserum Product and Solutions
2.16.4 Rare Disease Therapeutics Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Rare Disease Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antiserum Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Antiserum by Company Revenue
3.2.2 Top 3 Antiserum Players Market Share in 2023
3.2.3 Top 6 Antiserum Players Market Share in 2023
3.3 Antiserum Market: Overall Company Footprint Analysis
3.3.1 Antiserum Market: Region Footprint
3.3.2 Antiserum Market: Company Product Type Footprint
3.3.3 Antiserum Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antiserum Consumption Value and Market Share by Type (2019-2024)
4.2 Global Antiserum Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antiserum Consumption Value Market Share by Application (2019-2024)
5.2 Global Antiserum Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Antiserum Consumption Value by Type (2019-2030)
6.2 North America Antiserum Consumption Value by Application (2019-2030)
6.3 North America Antiserum Market Size by Country
6.3.1 North America Antiserum Consumption Value by Country (2019-2030)
6.3.2 United States Antiserum Market Size and Forecast (2019-2030)
6.3.3 Canada Antiserum Market Size and Forecast (2019-2030)
6.3.4 Mexico Antiserum Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Antiserum Consumption Value by Type (2019-2030)
7.2 Europe Antiserum Consumption Value by Application (2019-2030)
7.3 Europe Antiserum Market Size by Country
7.3.1 Europe Antiserum Consumption Value by Country (2019-2030)
7.3.2 Germany Antiserum Market Size and Forecast (2019-2030)
7.3.3 France Antiserum Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Antiserum Market Size and Forecast (2019-2030)
7.3.5 Russia Antiserum Market Size and Forecast (2019-2030)
7.3.6 Italy Antiserum Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antiserum Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Antiserum Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Antiserum Market Size by Region
8.3.1 Asia-Pacific Antiserum Consumption Value by Region (2019-2030)
8.3.2 China Antiserum Market Size and Forecast (2019-2030)
8.3.3 Japan Antiserum Market Size and Forecast (2019-2030)
8.3.4 South Korea Antiserum Market Size and Forecast (2019-2030)
8.3.5 India Antiserum Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Antiserum Market Size and Forecast (2019-2030)
8.3.7 Australia Antiserum Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Antiserum Consumption Value by Type (2019-2030)
9.2 South America Antiserum Consumption Value by Application (2019-2030)
9.3 South America Antiserum Market Size by Country
9.3.1 South America Antiserum Consumption Value by Country (2019-2030)
9.3.2 Brazil Antiserum Market Size and Forecast (2019-2030)
9.3.3 Argentina Antiserum Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antiserum Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Antiserum Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Antiserum Market Size by Country
10.3.1 Middle East & Africa Antiserum Consumption Value by Country (2019-2030)
10.3.2 Turkey Antiserum Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Antiserum Market Size and Forecast (2019-2030)
10.3.4 UAE Antiserum Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Antiserum Market Drivers
11.2 Antiserum Market Restraints
11.3 Antiserum Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Antiserum Industry Chain
12.2 Antiserum Upstream Analysis
12.3 Antiserum Midstream Analysis
12.4 Antiserum Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Antiserum
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Antiserum by Type
1.3.1 Overview: Global Antiserum Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Antiserum Consumption Value Market Share by Type in 2023
1.3.3 Antitoxin Serum
1.3.4 Antibacterial Serum
1.3.5 Antiviral Serum
1.3.6 Others
1.4 Global Antiserum Market by Application
1.4.1 Overview: Global Antiserum Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinical
1.4.3 Laboratory
1.5 Global Antiserum Market Size & Forecast
1.6 Global Antiserum Market Size and Forecast by Region
1.6.1 Global Antiserum Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Antiserum Market Size by Region, (2019-2030)
1.6.3 North America Antiserum Market Size and Prospect (2019-2030)
1.6.4 Europe Antiserum Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Antiserum Market Size and Prospect (2019-2030)
1.6.6 South America Antiserum Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Antiserum Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Antiserum Product and Solutions
2.1.4 BD Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 BD Recent Developments and Future Plans
2.2 Bio-Rad
2.2.1 Bio-Rad Details
2.2.2 Bio-Rad Major Business
2.2.3 Bio-Rad Antiserum Product and Solutions
2.2.4 Bio-Rad Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bio-Rad Recent Developments and Future Plans
2.3 Shanghai Serum Bio-Technology Co., Ltd.
2.3.1 Shanghai Serum Bio-Technology Co., Ltd. Details
2.3.2 Shanghai Serum Bio-Technology Co., Ltd. Major Business
2.3.3 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product and Solutions
2.3.4 Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Shanghai Serum Bio-Technology Co., Ltd. Recent Developments and Future Plans
2.4 China National Pharmaceutical Group
2.4.1 China National Pharmaceutical Group Details
2.4.2 China National Pharmaceutical Group Major Business
2.4.3 China National Pharmaceutical Group Antiserum Product and Solutions
2.4.4 China National Pharmaceutical Group Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 China National Pharmaceutical Group Recent Developments and Future Plans
2.5 CSL
2.5.1 CSL Details
2.5.2 CSL Major Business
2.5.3 CSL Antiserum Product and Solutions
2.5.4 CSL Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 CSL Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Antiserum Product and Solutions
2.6.4 Merck Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Merck Recent Developments and Future Plans
2.7 BTG
2.7.1 BTG Details
2.7.2 BTG Major Business
2.7.3 BTG Antiserum Product and Solutions
2.7.4 BTG Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BTG Recent Developments and Future Plans
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business
2.8.3 Pfizer Antiserum Product and Solutions
2.8.4 Pfizer Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Pfizer Recent Developments and Future Plans
2.9 Haffkine Bio-Pharmaceutical
2.9.1 Haffkine Bio-Pharmaceutical Details
2.9.2 Haffkine Bio-Pharmaceutical Major Business
2.9.3 Haffkine Bio-Pharmaceutical Antiserum Product and Solutions
2.9.4 Haffkine Bio-Pharmaceutical Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Haffkine Bio-Pharmaceutical Recent Developments and Future Plans
2.10 Vins Bioproducts
2.10.1 Vins Bioproducts Details
2.10.2 Vins Bioproducts Major Business
2.10.3 Vins Bioproducts Antiserum Product and Solutions
2.10.4 Vins Bioproducts Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Vins Bioproducts Recent Developments and Future Plans
2.11 Bharat Serums and Vaccines
2.11.1 Bharat Serums and Vaccines Details
2.11.2 Bharat Serums and Vaccines Major Business
2.11.3 Bharat Serums and Vaccines Antiserum Product and Solutions
2.11.4 Bharat Serums and Vaccines Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bharat Serums and Vaccines Recent Developments and Future Plans
2.12 SSI Diagnostica
2.12.1 SSI Diagnostica Details
2.12.2 SSI Diagnostica Major Business
2.12.3 SSI Diagnostica Antiserum Product and Solutions
2.12.4 SSI Diagnostica Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 SSI Diagnostica Recent Developments and Future Plans
2.13 GD Animal Health
2.13.1 GD Animal Health Details
2.13.2 GD Animal Health Major Business
2.13.3 GD Animal Health Antiserum Product and Solutions
2.13.4 GD Animal Health Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 GD Animal Health Recent Developments and Future Plans
2.14 MicroPharm
2.14.1 MicroPharm Details
2.14.2 MicroPharm Major Business
2.14.3 MicroPharm Antiserum Product and Solutions
2.14.4 MicroPharm Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 MicroPharm Recent Developments and Future Plans
2.15 Peptide Institute Inc.
2.15.1 Peptide Institute Inc. Details
2.15.2 Peptide Institute Inc. Major Business
2.15.3 Peptide Institute Inc. Antiserum Product and Solutions
2.15.4 Peptide Institute Inc. Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Peptide Institute Inc. Recent Developments and Future Plans
2.16 Rare Disease Therapeutics
2.16.1 Rare Disease Therapeutics Details
2.16.2 Rare Disease Therapeutics Major Business
2.16.3 Rare Disease Therapeutics Antiserum Product and Solutions
2.16.4 Rare Disease Therapeutics Antiserum Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Rare Disease Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Antiserum Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Antiserum by Company Revenue
3.2.2 Top 3 Antiserum Players Market Share in 2023
3.2.3 Top 6 Antiserum Players Market Share in 2023
3.3 Antiserum Market: Overall Company Footprint Analysis
3.3.1 Antiserum Market: Region Footprint
3.3.2 Antiserum Market: Company Product Type Footprint
3.3.3 Antiserum Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Antiserum Consumption Value and Market Share by Type (2019-2024)
4.2 Global Antiserum Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Antiserum Consumption Value Market Share by Application (2019-2024)
5.2 Global Antiserum Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Antiserum Consumption Value by Type (2019-2030)
6.2 North America Antiserum Consumption Value by Application (2019-2030)
6.3 North America Antiserum Market Size by Country
6.3.1 North America Antiserum Consumption Value by Country (2019-2030)
6.3.2 United States Antiserum Market Size and Forecast (2019-2030)
6.3.3 Canada Antiserum Market Size and Forecast (2019-2030)
6.3.4 Mexico Antiserum Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Antiserum Consumption Value by Type (2019-2030)
7.2 Europe Antiserum Consumption Value by Application (2019-2030)
7.3 Europe Antiserum Market Size by Country
7.3.1 Europe Antiserum Consumption Value by Country (2019-2030)
7.3.2 Germany Antiserum Market Size and Forecast (2019-2030)
7.3.3 France Antiserum Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Antiserum Market Size and Forecast (2019-2030)
7.3.5 Russia Antiserum Market Size and Forecast (2019-2030)
7.3.6 Italy Antiserum Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Antiserum Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Antiserum Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Antiserum Market Size by Region
8.3.1 Asia-Pacific Antiserum Consumption Value by Region (2019-2030)
8.3.2 China Antiserum Market Size and Forecast (2019-2030)
8.3.3 Japan Antiserum Market Size and Forecast (2019-2030)
8.3.4 South Korea Antiserum Market Size and Forecast (2019-2030)
8.3.5 India Antiserum Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Antiserum Market Size and Forecast (2019-2030)
8.3.7 Australia Antiserum Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Antiserum Consumption Value by Type (2019-2030)
9.2 South America Antiserum Consumption Value by Application (2019-2030)
9.3 South America Antiserum Market Size by Country
9.3.1 South America Antiserum Consumption Value by Country (2019-2030)
9.3.2 Brazil Antiserum Market Size and Forecast (2019-2030)
9.3.3 Argentina Antiserum Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Antiserum Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Antiserum Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Antiserum Market Size by Country
10.3.1 Middle East & Africa Antiserum Consumption Value by Country (2019-2030)
10.3.2 Turkey Antiserum Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Antiserum Market Size and Forecast (2019-2030)
10.3.4 UAE Antiserum Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Antiserum Market Drivers
11.2 Antiserum Market Restraints
11.3 Antiserum Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Antiserum Industry Chain
12.2 Antiserum Upstream Analysis
12.3 Antiserum Midstream Analysis
12.4 Antiserum Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Antiserum Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Antiserum Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Antiserum Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Antiserum Consumption Value by Region (2025-2030) & (USD Million)
Table 5. BD Company Information, Head Office, and Major Competitors
Table 6. BD Major Business
Table 7. BD Antiserum Product and Solutions
Table 8. BD Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. BD Recent Developments and Future Plans
Table 10. Bio-Rad Company Information, Head Office, and Major Competitors
Table 11. Bio-Rad Major Business
Table 12. Bio-Rad Antiserum Product and Solutions
Table 13. Bio-Rad Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Bio-Rad Recent Developments and Future Plans
Table 15. Shanghai Serum Bio-Technology Co., Ltd. Company Information, Head Office, and Major Competitors
Table 16. Shanghai Serum Bio-Technology Co., Ltd. Major Business
Table 17. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product and Solutions
Table 18. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Shanghai Serum Bio-Technology Co., Ltd. Recent Developments and Future Plans
Table 20. China National Pharmaceutical Group Company Information, Head Office, and Major Competitors
Table 21. China National Pharmaceutical Group Major Business
Table 22. China National Pharmaceutical Group Antiserum Product and Solutions
Table 23. China National Pharmaceutical Group Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. China National Pharmaceutical Group Recent Developments and Future Plans
Table 25. CSL Company Information, Head Office, and Major Competitors
Table 26. CSL Major Business
Table 27. CSL Antiserum Product and Solutions
Table 28. CSL Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. CSL Recent Developments and Future Plans
Table 30. Merck Company Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Antiserum Product and Solutions
Table 33. Merck Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Merck Recent Developments and Future Plans
Table 35. BTG Company Information, Head Office, and Major Competitors
Table 36. BTG Major Business
Table 37. BTG Antiserum Product and Solutions
Table 38. BTG Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. BTG Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Antiserum Product and Solutions
Table 43. Pfizer Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Haffkine Bio-Pharmaceutical Company Information, Head Office, and Major Competitors
Table 46. Haffkine Bio-Pharmaceutical Major Business
Table 47. Haffkine Bio-Pharmaceutical Antiserum Product and Solutions
Table 48. Haffkine Bio-Pharmaceutical Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Haffkine Bio-Pharmaceutical Recent Developments and Future Plans
Table 50. Vins Bioproducts Company Information, Head Office, and Major Competitors
Table 51. Vins Bioproducts Major Business
Table 52. Vins Bioproducts Antiserum Product and Solutions
Table 53. Vins Bioproducts Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Vins Bioproducts Recent Developments and Future Plans
Table 55. Bharat Serums and Vaccines Company Information, Head Office, and Major Competitors
Table 56. Bharat Serums and Vaccines Major Business
Table 57. Bharat Serums and Vaccines Antiserum Product and Solutions
Table 58. Bharat Serums and Vaccines Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Bharat Serums and Vaccines Recent Developments and Future Plans
Table 60. SSI Diagnostica Company Information, Head Office, and Major Competitors
Table 61. SSI Diagnostica Major Business
Table 62. SSI Diagnostica Antiserum Product and Solutions
Table 63. SSI Diagnostica Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. SSI Diagnostica Recent Developments and Future Plans
Table 65. GD Animal Health Company Information, Head Office, and Major Competitors
Table 66. GD Animal Health Major Business
Table 67. GD Animal Health Antiserum Product and Solutions
Table 68. GD Animal Health Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. GD Animal Health Recent Developments and Future Plans
Table 70. MicroPharm Company Information, Head Office, and Major Competitors
Table 71. MicroPharm Major Business
Table 72. MicroPharm Antiserum Product and Solutions
Table 73. MicroPharm Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. MicroPharm Recent Developments and Future Plans
Table 75. Peptide Institute Inc. Company Information, Head Office, and Major Competitors
Table 76. Peptide Institute Inc. Major Business
Table 77. Peptide Institute Inc. Antiserum Product and Solutions
Table 78. Peptide Institute Inc. Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Peptide Institute Inc. Recent Developments and Future Plans
Table 80. Rare Disease Therapeutics Company Information, Head Office, and Major Competitors
Table 81. Rare Disease Therapeutics Major Business
Table 82. Rare Disease Therapeutics Antiserum Product and Solutions
Table 83. Rare Disease Therapeutics Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Rare Disease Therapeutics Recent Developments and Future Plans
Table 85. Global Antiserum Revenue (USD Million) by Players (2019-2024)
Table 86. Global Antiserum Revenue Share by Players (2019-2024)
Table 87. Breakdown of Antiserum by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Antiserum, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Antiserum Players
Table 90. Antiserum Market: Company Product Type Footprint
Table 91. Antiserum Market: Company Product Application Footprint
Table 92. Antiserum New Market Entrants and Barriers to Market Entry
Table 93. Antiserum Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Antiserum Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Antiserum Consumption Value Share by Type (2019-2024)
Table 96. Global Antiserum Consumption Value Forecast by Type (2025-2030)
Table 97. Global Antiserum Consumption Value by Application (2019-2024)
Table 98. Global Antiserum Consumption Value Forecast by Application (2025-2030)
Table 99. North America Antiserum Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Antiserum Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Antiserum Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Antiserum Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Antiserum Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Antiserum Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Antiserum Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Antiserum Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Antiserum Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Antiserum Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Antiserum Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Antiserum Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Antiserum Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Antiserum Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Antiserum Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Antiserum Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Antiserum Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Antiserum Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Antiserum Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Antiserum Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Antiserum Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Antiserum Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Antiserum Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Antiserum Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Antiserum Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Antiserum Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Antiserum Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Antiserum Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Antiserum Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Antiserum Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Antiserum Raw Material
Table 130. Key Suppliers of Antiserum Raw Materials
Table 1. Global Antiserum Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Antiserum Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Antiserum Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Antiserum Consumption Value by Region (2025-2030) & (USD Million)
Table 5. BD Company Information, Head Office, and Major Competitors
Table 6. BD Major Business
Table 7. BD Antiserum Product and Solutions
Table 8. BD Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. BD Recent Developments and Future Plans
Table 10. Bio-Rad Company Information, Head Office, and Major Competitors
Table 11. Bio-Rad Major Business
Table 12. Bio-Rad Antiserum Product and Solutions
Table 13. Bio-Rad Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Bio-Rad Recent Developments and Future Plans
Table 15. Shanghai Serum Bio-Technology Co., Ltd. Company Information, Head Office, and Major Competitors
Table 16. Shanghai Serum Bio-Technology Co., Ltd. Major Business
Table 17. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Product and Solutions
Table 18. Shanghai Serum Bio-Technology Co., Ltd. Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Shanghai Serum Bio-Technology Co., Ltd. Recent Developments and Future Plans
Table 20. China National Pharmaceutical Group Company Information, Head Office, and Major Competitors
Table 21. China National Pharmaceutical Group Major Business
Table 22. China National Pharmaceutical Group Antiserum Product and Solutions
Table 23. China National Pharmaceutical Group Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. China National Pharmaceutical Group Recent Developments and Future Plans
Table 25. CSL Company Information, Head Office, and Major Competitors
Table 26. CSL Major Business
Table 27. CSL Antiserum Product and Solutions
Table 28. CSL Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. CSL Recent Developments and Future Plans
Table 30. Merck Company Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Antiserum Product and Solutions
Table 33. Merck Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Merck Recent Developments and Future Plans
Table 35. BTG Company Information, Head Office, and Major Competitors
Table 36. BTG Major Business
Table 37. BTG Antiserum Product and Solutions
Table 38. BTG Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. BTG Recent Developments and Future Plans
Table 40. Pfizer Company Information, Head Office, and Major Competitors
Table 41. Pfizer Major Business
Table 42. Pfizer Antiserum Product and Solutions
Table 43. Pfizer Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Pfizer Recent Developments and Future Plans
Table 45. Haffkine Bio-Pharmaceutical Company Information, Head Office, and Major Competitors
Table 46. Haffkine Bio-Pharmaceutical Major Business
Table 47. Haffkine Bio-Pharmaceutical Antiserum Product and Solutions
Table 48. Haffkine Bio-Pharmaceutical Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Haffkine Bio-Pharmaceutical Recent Developments and Future Plans
Table 50. Vins Bioproducts Company Information, Head Office, and Major Competitors
Table 51. Vins Bioproducts Major Business
Table 52. Vins Bioproducts Antiserum Product and Solutions
Table 53. Vins Bioproducts Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Vins Bioproducts Recent Developments and Future Plans
Table 55. Bharat Serums and Vaccines Company Information, Head Office, and Major Competitors
Table 56. Bharat Serums and Vaccines Major Business
Table 57. Bharat Serums and Vaccines Antiserum Product and Solutions
Table 58. Bharat Serums and Vaccines Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Bharat Serums and Vaccines Recent Developments and Future Plans
Table 60. SSI Diagnostica Company Information, Head Office, and Major Competitors
Table 61. SSI Diagnostica Major Business
Table 62. SSI Diagnostica Antiserum Product and Solutions
Table 63. SSI Diagnostica Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. SSI Diagnostica Recent Developments and Future Plans
Table 65. GD Animal Health Company Information, Head Office, and Major Competitors
Table 66. GD Animal Health Major Business
Table 67. GD Animal Health Antiserum Product and Solutions
Table 68. GD Animal Health Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. GD Animal Health Recent Developments and Future Plans
Table 70. MicroPharm Company Information, Head Office, and Major Competitors
Table 71. MicroPharm Major Business
Table 72. MicroPharm Antiserum Product and Solutions
Table 73. MicroPharm Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. MicroPharm Recent Developments and Future Plans
Table 75. Peptide Institute Inc. Company Information, Head Office, and Major Competitors
Table 76. Peptide Institute Inc. Major Business
Table 77. Peptide Institute Inc. Antiserum Product and Solutions
Table 78. Peptide Institute Inc. Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Peptide Institute Inc. Recent Developments and Future Plans
Table 80. Rare Disease Therapeutics Company Information, Head Office, and Major Competitors
Table 81. Rare Disease Therapeutics Major Business
Table 82. Rare Disease Therapeutics Antiserum Product and Solutions
Table 83. Rare Disease Therapeutics Antiserum Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Rare Disease Therapeutics Recent Developments and Future Plans
Table 85. Global Antiserum Revenue (USD Million) by Players (2019-2024)
Table 86. Global Antiserum Revenue Share by Players (2019-2024)
Table 87. Breakdown of Antiserum by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Antiserum, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Antiserum Players
Table 90. Antiserum Market: Company Product Type Footprint
Table 91. Antiserum Market: Company Product Application Footprint
Table 92. Antiserum New Market Entrants and Barriers to Market Entry
Table 93. Antiserum Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Antiserum Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Antiserum Consumption Value Share by Type (2019-2024)
Table 96. Global Antiserum Consumption Value Forecast by Type (2025-2030)
Table 97. Global Antiserum Consumption Value by Application (2019-2024)
Table 98. Global Antiserum Consumption Value Forecast by Application (2025-2030)
Table 99. North America Antiserum Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Antiserum Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Antiserum Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Antiserum Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Antiserum Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Antiserum Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Antiserum Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Antiserum Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Antiserum Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Antiserum Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Antiserum Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Antiserum Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Antiserum Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Antiserum Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Antiserum Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Antiserum Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Antiserum Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Antiserum Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Antiserum Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Antiserum Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Antiserum Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Antiserum Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Antiserum Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Antiserum Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Antiserum Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Antiserum Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Antiserum Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Antiserum Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Antiserum Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Antiserum Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Antiserum Raw Material
Table 130. Key Suppliers of Antiserum Raw Materials
LIST OF FIGURES
Figure 1. Antiserum Picture
Figure 2. Global Antiserum Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Antiserum Consumption Value Market Share by Type in 2023
Figure 4. Antitoxin Serum
Figure 5. Antibacterial Serum
Figure 6. Antiviral Serum
Figure 7. Others
Figure 8. Global Antiserum Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Antiserum Consumption Value Market Share by Application in 2023
Figure 10. Clinical Picture
Figure 11. Laboratory Picture
Figure 12. Global Antiserum Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Antiserum Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Antiserum Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Antiserum Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Antiserum Consumption Value Market Share by Region in 2023
Figure 17. North America Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Antiserum Revenue Share by Players in 2023
Figure 23. Antiserum Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Antiserum Market Share in 2023
Figure 25. Global Top 6 Players Antiserum Market Share in 2023
Figure 26. Global Antiserum Consumption Value Share by Type (2019-2024)
Figure 27. Global Antiserum Market Share Forecast by Type (2025-2030)
Figure 28. Global Antiserum Consumption Value Share by Application (2019-2024)
Figure 29. Global Antiserum Market Share Forecast by Application (2025-2030)
Figure 30. North America Antiserum Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Antiserum Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Antiserum Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Antiserum Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Antiserum Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Antiserum Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 40. France Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Antiserum Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Antiserum Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Antiserum Consumption Value Market Share by Region (2019-2030)
Figure 47. China Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 50. India Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Antiserum Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Antiserum Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Antiserum Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Antiserum Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Antiserum Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Antiserum Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 64. Antiserum Market Drivers
Figure 65. Antiserum Market Restraints
Figure 66. Antiserum Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Antiserum in 2023
Figure 69. Manufacturing Process Analysis of Antiserum
Figure 70. Antiserum Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Antiserum Picture
Figure 2. Global Antiserum Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Antiserum Consumption Value Market Share by Type in 2023
Figure 4. Antitoxin Serum
Figure 5. Antibacterial Serum
Figure 6. Antiviral Serum
Figure 7. Others
Figure 8. Global Antiserum Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Antiserum Consumption Value Market Share by Application in 2023
Figure 10. Clinical Picture
Figure 11. Laboratory Picture
Figure 12. Global Antiserum Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Antiserum Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Antiserum Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Antiserum Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Antiserum Consumption Value Market Share by Region in 2023
Figure 17. North America Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Antiserum Revenue Share by Players in 2023
Figure 23. Antiserum Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Antiserum Market Share in 2023
Figure 25. Global Top 6 Players Antiserum Market Share in 2023
Figure 26. Global Antiserum Consumption Value Share by Type (2019-2024)
Figure 27. Global Antiserum Market Share Forecast by Type (2025-2030)
Figure 28. Global Antiserum Consumption Value Share by Application (2019-2024)
Figure 29. Global Antiserum Market Share Forecast by Application (2025-2030)
Figure 30. North America Antiserum Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Antiserum Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Antiserum Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Antiserum Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Antiserum Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Antiserum Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 40. France Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Antiserum Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Antiserum Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Antiserum Consumption Value Market Share by Region (2019-2030)
Figure 47. China Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 50. India Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Antiserum Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Antiserum Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Antiserum Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Antiserum Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Antiserum Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Antiserum Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Antiserum Consumption Value (2019-2030) & (USD Million)
Figure 64. Antiserum Market Drivers
Figure 65. Antiserum Market Restraints
Figure 66. Antiserum Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Antiserum in 2023
Figure 69. Manufacturing Process Analysis of Antiserum
Figure 70. Antiserum Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
